Announcements Trials
Browse Landscape

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 1Craniopharyngioma 1

Interventions

Educational Status 5Interviews as Topic 4Methods 3Early Intervention, Educational 3Cisplatin 3Blood Specimen Collection 3pembrolizumab 2Surveys and Questionnaires 2Standard of Care 2Nivolumab 2Music Therapy 2Magnetic Resonance Imaging 2Gemcitabine 2Counseling 2zilucoplan 1tislelizumab 1somapacitan 1sacituzumab govitecan 1rozanolixizumab 1oxycodone-acetaminophen 1ibrutinib 1futibatinib 1fluorodopa F 18 1erdafitinib 1enzalutamide 1enfortumab vedotin 1dynorphin-converting endopeptidase 1durvalumab 1dalpiciclib 1brexucabtagene autoleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Tumor Burden × 90 days × Clear all
NCT03610906 2026-03-23

Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

University of Colorado, Denver

Enrolling by invitation
250 enrolled
CNS

Craniopharyngioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡